These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Growth hormone inhibitory and stimulatory actions of L-dopa in patients with acromegaly. Hanew K, Sasaki A, Sato S, Goh M, Yoshinaga K. J Clin Endocrinol Metab; 1987 Feb; 64(2):255-60. PubMed ID: 3793848 [Abstract] [Full Text] [Related]
5. [The effects of l-dopa administration on the prolactin levels in short-stature subjects]. Saggese G, Cesaretti G, Carlotti C, Cioni C, Bracaloni C. Minerva Pediatr; 1992 Mar; 44(3):73-8. PubMed ID: 1518496 [Abstract] [Full Text] [Related]
6. Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors. Fine SA, Frohman LA. J Clin Invest; 1978 Apr; 61(4):973-80. PubMed ID: 659585 [Abstract] [Full Text] [Related]
7. Carbidopa inhibits the growth hormone- and prolactin-suppressive effect of L-dopa in acromegalic patients. Camanni F, Picotti GB, Massara F, Molinatti GM, Mantegazza P, Müller EE. J Clin Endocrinol Metab; 1978 Sep; 47(3):647-52. PubMed ID: 263317 [Abstract] [Full Text] [Related]
8. Hypothalamic-pituitary control of perinatal prolactin secretion in Macaca mulatta. Epstein MF, Chez RA, Oakes GK, Vaitukaitis JL. Endocrinology; 1976 Sep; 99(3):743-51. PubMed ID: 821744 [Abstract] [Full Text] [Related]
9. Inhibitory effect of cimetidine on L-dopa-stimulated growth hormone release in normal man. Zanoboni A, Galmozzi G, Marinoni S, Zanoboni-Muciaccia W. Clin Endocrinol (Oxf); 1984 Nov; 21(5):535-40. PubMed ID: 6499233 [Abstract] [Full Text] [Related]
10. Calcium and calcium-antagonistic effects on prolactin and growth hormone responses to thyrotropin-releasing hormone and L-dopa in man. Röjdmark S, Andersson DE, Sundblad L. J Clin Endocrinol Metab; 1981 Sep; 53(3):594-8. PubMed ID: 6790560 [Abstract] [Full Text] [Related]
11. [The correlationship between basal prolactin levels and the suppressive effect of CB-154 or L-DOPA on GH release in acromegalic patients (author's transl)]. Hara I, Kataoka K, Tomita A, Takanohashi M, Nakane T, Kuwayama A, Kageyama N. Nihon Naibunpi Gakkai Zasshi; 1979 Jan 20; 55(1):16-24. PubMed ID: 581754 [Abstract] [Full Text] [Related]
14. Hypothalamo-pituitary dopaminergic system in patients with myotonic dystrophy. Sakuma H, Takase S, Mizuno Y, Teramura K, Hanew K. Tohoku J Exp Med; 1988 Nov 20; 156(3):291-8. PubMed ID: 3252557 [Abstract] [Full Text] [Related]
15. Hypothalamic and pituitary sites of action of oxytocin to alter prolactin secretion in the rat. Lumpkin MD, Samson WK, McCann SM. Endocrinology; 1983 May 20; 112(5):1711-7. PubMed ID: 6403333 [Abstract] [Full Text] [Related]
17. Variable plasma growth hormone (GH)-releasing hormone and GH responses to clonidine, L-dopa, and insulin in normal men. Tapanainen P, Knip M, Lautala P, Leppäluoto J. J Clin Endocrinol Metab; 1988 Oct 20; 67(4):845-9. PubMed ID: 3138280 [Abstract] [Full Text] [Related]
18. [Behavior of growth hormone after stimulation with growth hormone releasing hormone (GHRH) in children with disorders of the hypothalamo-hypophyseal axis and girls with Turner syndrome]. Schmitt K, Schober E, Birnbacher R, Frisch H. Klin Padiatr; 1996 Oct 20; 208(1):29-34. PubMed ID: 8851324 [Abstract] [Full Text] [Related]
19. [Responses of growth hormone and prolactin to L-Dopa in women with polycystic ovarian syndrome]. Wu X, Gu Q, Su Y. Zhonghua Fu Chan Ke Za Zhi; 1997 Aug 20; 32(8):489-91. PubMed ID: 9639745 [Abstract] [Full Text] [Related]
20. Effect of experimentally induced hyperprolactinemia on growth hormone secretion. Esquifino AI, Fernández-Ruiz JJ, Cebeira M, Agrasal C, Tresguerres JA, Ramos JA. Rev Esp Fisiol; 1987 Dec 20; 43(4):463-8. PubMed ID: 3448711 [Abstract] [Full Text] [Related] Page: [Next] [New Search]